Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance

S. Stuard, C. Ridel, M. Cioffi, A. Trost-Rupnik, K. Gurevich, M. Bojic, Y. Karibayev, N. Mohebbi, W. Marcinkowski, V. Kupres, J. Maslovaric, A. Antebi, P. Ponce, M. Nada, MEB. Salvador, J. Rosenberger, T. Jirka, K. Enden, V. Novakivskyy, D....

. 2024 ; 13 (11) : . [pub] 20240530

Status not-indexed Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc24012670

The demographic profile of patients transitioning from chronic kidney disease to kidney replacement therapy is changing, with a higher prevalence of aging patients with multiple comorbidities such as diabetes mellitus and heart failure. Cardiovascular disease remains the leading cause of mortality in this population, exacerbated by the cardiovascular stress imposed by the HD procedure. The first year after transitioning to hemodialysis is associated with increased risks of hospitalization and mortality, particularly within the first 90-120 days, with greater vulnerability observed among the elderly. Based on data from clinics in Fresenius Medical Care Europe, Middle East, and Africa NephroCare, this review aims to optimize hemodialysis procedures to reduce mortality risk in stable incident and prevalent patients. It addresses critical aspects such as treatment duration, frequency, choice of dialysis membrane, dialysate composition, blood and dialysate flow rates, electrolyte composition, temperature control, target weight management, dialysis adequacy, and additional protocols, with a focus on mitigating prevalent intradialytic complications, particularly intradialytic hypotension prevention.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012670
003      
CZ-PrNML
005      
20240726151332.0
007      
ta
008      
240723s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm13113211 $2 doi
035    __
$a (PubMed)38892922
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Stuard, Stefano $u FME Global Medical Office, 61352 Bad Homburg, Germany $1 https://orcid.org/0000000295464507
245    10
$a Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance / $c S. Stuard, C. Ridel, M. Cioffi, A. Trost-Rupnik, K. Gurevich, M. Bojic, Y. Karibayev, N. Mohebbi, W. Marcinkowski, V. Kupres, J. Maslovaric, A. Antebi, P. Ponce, M. Nada, MEB. Salvador, J. Rosenberger, T. Jirka, K. Enden, V. Novakivskyy, D. Voiculescu, M. Pachmann, O. Arkossy
520    9_
$a The demographic profile of patients transitioning from chronic kidney disease to kidney replacement therapy is changing, with a higher prevalence of aging patients with multiple comorbidities such as diabetes mellitus and heart failure. Cardiovascular disease remains the leading cause of mortality in this population, exacerbated by the cardiovascular stress imposed by the HD procedure. The first year after transitioning to hemodialysis is associated with increased risks of hospitalization and mortality, particularly within the first 90-120 days, with greater vulnerability observed among the elderly. Based on data from clinics in Fresenius Medical Care Europe, Middle East, and Africa NephroCare, this review aims to optimize hemodialysis procedures to reduce mortality risk in stable incident and prevalent patients. It addresses critical aspects such as treatment duration, frequency, choice of dialysis membrane, dialysate composition, blood and dialysate flow rates, electrolyte composition, temperature control, target weight management, dialysis adequacy, and additional protocols, with a focus on mitigating prevalent intradialytic complications, particularly intradialytic hypotension prevention.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Ridel, Christophe $u FME Global Medical Office, 94260 Fresnes, France
700    1_
$a Cioffi, Mario $u FME Global Medical Office, 80133 Napoli, Italy
700    1_
$a Trost-Rupnik, Alijana $u FME Global Medical Office, 1351 Brezovica pri Ljubljani, Slovenia
700    1_
$a Gurevich, Konstantin $u FME Global Medical Office, Saint Petersburg 194354, Russia
700    1_
$a Bojic, Marija $u FME Global Medical Office, 75400 Zvornik, Bosnia and Herzegovina
700    1_
$a Karibayev, Yerkebulan $u FME Global Medical Office, Almaty 050003, Kazakhstan
700    1_
$a Mohebbi, Nilufar $u FME Global Medical Office, 8002 Zurich, Switzerland $1 https://orcid.org/0000000282299733
700    1_
$a Marcinkowski, Wojciech $u FME Global Medical Office, 60118 Poznań, Poland
700    1_
$a Kupres, Vlasta $u FME Global Medical Office, 49210 Zabok, Croatia
700    1_
$a Maslovaric, Jelena $u FME Global Medical Office, 11000 Beograd, Serbia
700    1_
$a Antebi, Alon $u FME Global Medical Office, Ra'anana 4366411, Israel
700    1_
$a Ponce, Pedro $u FME Global Medical Office, 1750-233 Lisboa, Portugal
700    1_
$a Nada, Mamdouh $u FME Global Medical Office, Riyadh 12472, Saudi Arabia
700    1_
$a Salvador, Maria Eva Baro $u FME Global Medical Office, 28760 Madrid, Spain $1 https://orcid.org/0009000769326198
700    1_
$a Rosenberger, Jaroslav $u FME Global Medical Office, 04011 Košice, Slovakia $1 https://orcid.org/000000017201889X $7 xx0107298
700    1_
$a Jirka, Tomas $u FME Global Medical Office, 16000 Praha, Czech Republic
700    1_
$a Enden, Kira $u FME Global Medical Office, 00380 Helsinki, Finland
700    1_
$a Novakivskyy, Volodymyr $u FME Global Medical Office, 02099 Kyiv, Ukraine
700    1_
$a Voiculescu, Daniela $u FME Global Medical Office, 013682 Bucuresti, Romania
700    1_
$a Pachmann, Martin $u FME Global Medical Office, 61352 Bad Homburg, Germany
700    1_
$a Arkossy, Otto $u FME Global Medical Office, 61352 Bad Homburg, Germany
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 13, č. 11 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38892922 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151325 $b ABA008
999    __
$a ok $b bmc $g 2125442 $s 1224533
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 13 $c 11 $e 20240530 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
LZP    __
$a Pubmed-20240723

Find record

Citation metrics

Archiving options